Recent Updates
Recently added Catalysts
KIDS Positive Sentiment Score: 85/100

OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division

Key Takeaway: OrthoPediatrics Corp. has announced the launch of its Specialty Bracing division, enhancing its focus on pediatric orthopedics through non-surgical interventions. This new division is expected to increase the company's market potential by about $600 million. The company has been building a robust portfolio in this area since acquiring MD Orthopaedics, and has introduced products such as the DF2® Brace for femur fracture fixation. Additionally, a partnership with Ora Medical aims to distribute a new gait-trainer device designed for children with walking difficulties.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of a new division focused on pediatric orthopedic bracing.
  • Expansion of the company's total addressable market by approximately $600 million.
  • Introduction of innovative products like the DF2® Brace and partnerships with other companies.

Full Press Release Details

WARSAW, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of a new division, focused on non-surgical intervention for pediatric orthopedics. The OrthoPediatrics Specialty Bracing division (“OPSB”) will serve as a flagship house of brands and innovative products that expand the Company’s Total Addressable Market by approximately $600 million.
The Company first entered the non-operative space through the acquisition of MD Orthopaedics, Inc. (MDO) in 2022, and their bracing product lines and the patented Mitchell Ponseti® Ankle-Foot Orthosis (AFO) system for the treatment of clubfoot. Since the transaction, the Company has been aggressively building a portfolio of complementary products to address the large unmet needs for specialty bracing within the pediatric orthopedic market. Earlier this year, MDO acquired the assets of Rhino Pediatric Orthopedic Designs, Inc., a San Diego based company founded by two pediatric orthopedic surgeons. The Rhino™ “Kicker” and “Cruiser” braces were designed for children with Developmental Dysplasia of the hip.
Additionally, the Company announced the release of the DF2® Brace as part of its expansion in the non-surgical business for treating kids with musculoskeletal injuries. The DF2® Brace is intended for femur fracture fixation in pediatric patients from approximately 6 months to 5 years of age instead of spica cast by providing immobilization of the femur, knee, and hip. Most recently, the Company announced a new partnership with Montreal-based Ora Medical, to distribute The Levity, a gait-trainer device designed for children with walking difficulties.
OrthoPediatrics’ President of Trauma & Deformity Correction, Joe Hauser will also lead the new non-operative business, commenting, “We are excited for the launch of the new OPSB division, and our continued expansion into pediatric orthopedic non-surgical treatments for kids. This new addition advances our growth strategy of providing a broad product portfolio uniquely designed to treat children while surrounding pediatric orthopedic surgeons with the most comprehensive product offering in the market.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 53 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Frequently Asked Questions

What is the new division launched by OrthoPediatrics?

OrthoPediatrics launched the Specialty Bracing division focusing on non-surgical interventions.

How much does the new division expand the Total Addressable Market?

The new division expands the Total Addressable Market by approximately $600 million.

What product lines are included in the new division?

The division includes patented bracing systems and products addressing specialty bracing needs.

Who will lead the new non-operative business at OrthoPediatrics?

Joe Hauser, President of Trauma & Deformity Correction, will lead the new non-operative business.

What is the DF2® Brace used for?

The DF2® Brace is used for femur fracture fixation in pediatric patients aged 6 months to 5 years.

Last updated: Dec 6, 2023